Preserving Beta-cell Function in Type 2 Diabetes With Exenatide and Insulin (PREVAIL)

NCT02194595 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

105

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: Basal insulin and exenatide
DRUG: Basal insulin only
DRUG: Basal insulin and bolus insulin

Sponsor

Mount Sinai Hospital, Canada

Collaborators

[object Object]
[object Object]